The Rt Hon Anneliese Dodds MP, Minister of State for Development, Minister of State for Women and Equalities and Oxford East MP, visited the Jenner Institute last week to discuss the very latest in malaria vaccine science.
Dr Matthew Bottomley from the CAMS Oxford Institute has been selected as the January winner of Cancer Research UK\u2019s Research is Beautiful Photography campaign.
Researchers in NDM have authored a collaborative study which explored a new method for detecting bowel cancer, which was found to be more than 90% accurate at predicting which higher-risk people will develop this type of cancer in the future.
Researchers in the Nuffield Department of Medicine and their collaborators, including the Serum Institute of India, have published an innovative method to identify falsified vaccines without opening the vaccine vial. The new method analyses the vaccine vial label and its adhesive and therefore allows genuine vaccine vials to be retained in the supply chain. This technique can also differentiate genuine Covid-19 vaccine liquid from falsified vaccine surrogates.
Professor Deirdre Hollingsworth, Professor of Infectious Disease Epidemiology at NDM\u2019s Centre for Tropical Medicine and Global Health and the Big Data Institute, looks at potential ways to advance research on the impact of climate change on malaria and neglected tropical diseases (NTDs).
Global biopharma company GSK invests up to \u00a350 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
The University of Oxford has once again been named the top institution in the Times Higher Education (THE) Subject Rankings for Clinical, Pre-Clinical, and Health, marking an impressive 14th consecutive year in this prestigious position.
New research from NDM\u2019s Target Discovery Institute, the MRC Laboratory of Molecular Biology and University College London has shed light on a potential pathway for the spread of harmful tau protein in Alzheimer's disease. Their findings, published in Nature Neuroscience, focus on structures called extracellular vesicles and their role in transporting toxic tau fragments.
Results of MOSAIC, a European observational study led by researchers at PSI and ISARIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission.
Led by Professor Yvonne Jones at the Division of Structural Biology and Professor David Strutt at the University of Sheffield's School of Biosciences, this \u00a33.7 million Wellcome Trust-funded project brings together cutting-edge technology and world-class expertise.
Dr Pablo F. C\u00e9spedes, CAMS Oxford Institute Career Development Fellow, has received funding from NC3Rs to establish a lymphoid organoid and explant hub for researchers across the country.
The Global Health Network has achieved a remarkable milestone: one million members worldwide. This dynamic and inclusive community of healthcare professionals and researchers is addressing two of the most pressing challenges in global health. By equipping teams to tackle everyday diseases of poverty and strengthening the ability to detect and respond to emerging threats, The Global Health Network is saving lives and safeguarding the future of global health.
Groundbreaking research by scientists from the Centre for Medicines Discovery at the Nuffield Department of Medicine opens up new possibilities for developing treatments that could both fight cancer and regulate the immune system, offering hope for better and more precise therapies in the future.
The Department wishes to announce that Professor Dame Sarah Gilbert has been appointed to the role of Deputy Head of Department of the Nuffield Department of Medicine for a five-year term.
An important step toward advancing vaccines for human use, a recent study has shown that inhaled vaccines could potentially improve efficiency and reduce viral transmission.
A new blood test \u2013 powered by machine learning \u2013 has shown real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect. Developed by a team of researchers and co-lead by the Centre for Human Genetics\u2019 Dr Dimitris Vavoulis, the test accurately detected six cancer types and could distinguish between people with and without cancer.
The Royal Society of Biology have recognised Associate Professor Benjamin Schuster-B\u00f6ckler from NDM's Ludwig Institute for Cancer Research as a Fellow in their January 2025 nominations round.
Mahidol Oxford Tropical Medicine Research Unit (MORU) have led the world\u2019s largest study on the use of hydroxychloroquine and chloroquine to prevent COVID-19. With results showing moderate protection against the virus, the trial involved over 4,600 participants and found a 15% reduction in symptomatic COVID-19 among those who took the medications compared to those who took a placebo.
A study aimed at increasing understanding of how cells function has received funding of \u00a36.4 million. Led by the University of Strathclyde, NDM\u2019s Division of Structural Biology (STRUBI) and collaborators from other universities across the UK will be working together to increase understanding in this area of research.
![\"\"](\"https://www.ndm.ox.ac.uk/news/anneliese-dodds-visits-the-jenner-institute/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n